Coherus Fends Off Amgen’s Pegfilgrastim Purification Patent Case
• By Aidan Fry
Coherus' chromatography steps for purifying pegfilgrastim do not infringe Amgen's US patent, the US Court of Appeals has confirmed • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
